Colchicine and indomethacin for the treatment of relapsing polychondritis

Journal of the American Academy of Dermatology

Volumn 46, Issue 2 II, 2002, Pages

  Mark, Kenneth A ^a,b   Franks Jr , Andrew G ^a,b  

^a New York University School of Medicine ^*  (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; COLCHICINE; INDOMETACIN; PREDNISONE; ANTIGOUT AGENT; ANTIINFLAMMATORY AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANAMNESIS; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; CASE REPORT; CONJUNCTIVITIS; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EPISCLERITIS; ERYTHEMA; HUMAN; LABORATORY TEST; MAINTENANCE DRUG DOSE; MALE; OTALGIA; OTITIS; PHYSICAL EXAMINATION; PRIORITY JOURNAL; RELAPSING POLYCHONDRITIS; SCLERA DISEASE; DRUG COMBINATION; IMMUNOLOGY; MIDDLE AGED;

ANTI-INFLAMMATORY AGENTS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; COLCHICINE; DRUG THERAPY, COMBINATION; GOUT SUPPRESSANTS; HUMANS; INDOMETHACIN; MALE; MIDDLE AGED; POLYCHONDRITIS, RELAPSING; PREDNISOLONE;

EID: 19044366752     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1067/mjd.2002.105477     Document Type: Article

References (30)

1. Katz SI. Relapsing polychondritis. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, editors. Dermatology in general medicine. 4th ed. New York: McGraw-Hill; 1993. p. 2183-5.
2. McAdam LP, O'Hanlan AM, Bluestone R, Rearson CM. Relapsing polychondritis: prospective study of 23 patients and a review of the literature. Medicine 1976;55:193-215.
3. Weismann K, Graham RM. Systemic disease and the skin. In: Champion RH, Burton JL, Ebling FJG, editors. Rook/Wilkinson/Ebling Textbook of Dermatology. 5th ed. London: Blackwell Scientific Publications; 1992. p. 2436-7 and 1799-1801.
4. Trentham DE. Relapsing polychondritis. In: Arndt KA, Le Boit PE, Robinson JK, Wintroub BU, editors. Cutaneous medicine and surgery. Philadelphia: WB Saunders; 1996. p.512-4.
5. Trentham DE, Le CH. Relapsing polychondritis. Ann Intern Med 1998;129:114-22.
6. Franks AG, Jr. Cutaneous manifestations of disorders of the cardiovascular and pulmonary systems. In: Fitzpatrick TB, Eisen AZ, Wolff K, Freedberg IM, Austen KF, editors. Dermatology in general medicine. 4th ed. New York: McGraw-Hill; 1993. p. 2063-77.
7. Askari AD. Colchicine for treatment of relapsing polychondritis. J Am Acad Dermatol 1984;10:507-10.
8. Estes SA. Relapsing polychondritis. Cutis 1983;32:471-4.
9. Svenson KL, Holmdahl R, Klareskog L, Wibell L, Sjoberg O, Klintmalm GB, et al. Cyclosporin A treatment in a case of relapsing polychondritis. Scand J Rheumatol 1984;13:329-33.
10. Anstey A, Mayou S, Morgan K, Clague RB, Munro DD. Relapsing polychondritis: autoimmunity to type II collagen and treatment with cyclosporin A. Br J Dermatol 1991;125:588-91.
11. Cremer MA, Rosloniec EF, Kang AH. The cartilage collagens: a review of their structure, organization, and role in the pathogenesis of experimental arthritis in animals and in human rheumatic disease. J Mol Med 1998;76:275-88.
12. Pitzalis C, Choy E, Kingsley G. Monoclonal antibody therapy in rheumatic disease. Presse Med 1994;23:532-9.
13. Saxne T, Heinegard D. Involvement of nonarticular cartilage, as demonstrated by release of a cartilage-specific protein, in rheumatoid arthritis. Arthritis Rheum 1989;32:1080-6.
14. Foldhart JM, Katz KI. Subtle clues to diagnosis of immunopathology: relapsing polychondritis.Am J Dermatopathol 1979;1:257-60.
15. Pesanti EL, Axline SG. Colchicine effects on lysosomal enzyme induction and intracellular degradation in the cultivated macrophage. J Exp Med 1975;141:1030-46.
16. Disdier P, Andrac L, Swiader L, Veit V, Fuzibet JG, Weiller-Merli C, et al. Cutaneous panniculitis and relapsing polychondritis: two cases. Dermatology 1996;193:266-8.
17. Rauh G, Kamilli I, Gresser U, Landthaler M. Relapsing polychondritis presenting as cutaneous polyarteritis nodosa. Clin Invest 1993;71:305-9.
18. Sidi Y, Weinberger A, Berliner S, Ben-Bassat M, Idesses C, Feuerman EJ, et al. Relapsing polychondritis associated with mixed cryoglobulinemia. Dermatologica 1982;165:66-70.
19. Bernard P, Bedane C, Delrous JL, Catanzano G, Bonnetblanc JM. Erythema elevatum diutinum in a patient with relapsing polychondritis. J Am Acad Dermatol 1992;26:312-5.
20. Massry GG, Chung SM, Selhorst JB. Optic neuropathy, headache, and diplopia with MRI suggestive of cerebral arteritis in relapsing polychondritis. J Neuroophthalmol 1995;5:171-5.
21. Small P, Black M, Davidman M, deChamplain ML, Kapusta MA, Kreisman H. Wegener's granulomatosis and relapsing polychondritis: a case report. J Rheumatol 1980;7:915-8.
22. Conti JA, Colicchio AR, Howard LM. Thymoma, myasthenia gravis, and relapsing polychondritis. Ann Intern Med 1988;109:163-4.
23. Manganelli P, Quaini F, Olivetti G, Savini M, Pileri S. Relapsing polychondritis with Castleman-like lymphadenopathy: a case report. Clin Rheumatol 1997;16:480-4.
24. Van Besien K, Tricot G, Hoffman R. Relapsing polychondritis: a paraneoplastic syndrome associated with myelodysplastic syndromes. Am J Hematol 1992;40:47-50.
25. Tyndall A. Hematopoietic stem cell transplantation in rheumatic diseases other than systemic sclerosis and systemic lupus erythematosus. J Rheumatol Suppl 1997;48:94-7.
26. Labarthe MP, Bayle-Lebey P, Bazex J. Cutaneous manifestations of relapsing polychondritis in a patient receiving goserelin for carcinoma of the prostate. Dermatology 1997;195:391-4.
27. Papo T, Wechsler B, Bletry O, Piette AM, Godeau P, Piette JC. Pregnancy in relapsing polychondritis: twenty-five pregnancies in eleven patients. Arthritis Rheum 1997;40:1245-9.
28. Bellamy N, Dewar CL. Relapsing polychondritis in pregnancy. J Rheumatol 1990;17:1525-6.
29. McEvoy GK. AHFS drug information. Bethesda: American Society of Health-System Pharmacists, Inc; 1998. p.3051-3.
30. Ronald A. Physicians desk reference. Montvale: Medical Economics Company, Inc; 1997. p. 1662-3.